Malignancy, Female Reproductive System with MCC: Inpatient Reimbursement Overview
DRG 754 addresses malignant neoplasms of the female reproductive system when a Major Complication or Comorbidity is present, encompassing complex gynecologic oncology admissions. Classification matters for inpatient reimbursement because higher clinical severity drives greater resource intensity and a higher Medicare payment weight under the Centers for Medicare & Medicaid Services payment framework.
Customize your policy alerts
Sign up for drg 754 policy alerts
Get alerted when payer policies referencing 754 are released or updated.
Monitor payer policy activity
DRG 754 Overview
DRG 754 covers hospital admissions for malignancies of the female reproductive system when a Major Complication or Comorbidity is present, typically including advanced gynecologic cancers with serious associated conditions or treatment complications. This Diagnosis-Related Group groups cases with higher resource use and clinical complexity, which directly impacts Medicare inpatient payment by assigning a higher relative weight compared with less severe reproductive system malignancy groups. Hospitals should recognize that the presence of a Major Complication or Comorbidity influences case classification and reimbursement under the Centers for Medicare & Medicaid Services inpatient prospective payment system. Accurate documentation of diagnoses and procedures is essential to align clinical care with appropriate payment classification.